Skip to content

David Reydellet

2 papers in the library · 25 citations · publishing 2024-2025

Papers

Sort Most recent Most cited

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Neuroscience of Consciousness 2025 Christopher Timmermann, James W. Sanders, David Reydellet et al. 19 citations

5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews,...

Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner

medRxiv September 11, 2024 Marek Nikolič, Pedro A. M. Mediano, Tom Froese et al. 6 citations preprint

Abstract Psilocybin is a classic psychedelic and a novel treatment for mood disorders. Psilocybin induces dose-dependent transient (4-6 hours) usually pleasant changes in perception, cognition, and emotion by non-selectively agonizing the 5-HT 2A receptors and negatively regulating serotonin reuptake, and long-term positive antidepressant effect on mood and well-being. Long-term effects are...